Holding Hands: Using Peptide-Drug Conjugates (PDCs) for the Precise Treatment of Pulmonary Fibrosis

Conferences

Physical and Life Sciences

Added by alexbrownss on 2024-11-03

Conference Dates:

Start Date: 2024-11-27
Last Date

Last Day: 2024-11-27

Conference Contact Info:

Contact Person: Alex Brown
Email

Email: [email protected]
Address

Address: New York City, USA, New York, New York, 11967, United States
Phone

Tel: 6314854226

Get Direction and MAP

Visit Website

Share |

Holding Hands: Using Peptide-Drug Conjugates (PDCs) for the Precise Treatment of Pulmonary Fibrosis

Enlarge Image

Conference Description:

Peptide drug conjugates (PDCs), a new tool for targeted therapy, consist of a targeting peptide, a linker, and an active drug. Dr Kelly's team synthesized a PDC series of PDCs designed to treat pulmonary fibrosis precisely, combining the kinase inhibitor nintedanib with a mimetic peptide chain targeting the ?V?6 integrin. Their antifibrotic activity is currently being evaluated in a mouse model of pulmonary fibrosis.

Back